Dexmedetomidine regulates exosomal miR-29b-3p from macrophages and alleviates septic myocardial injury by promoting autophagy in cardiomyocytes via targeting glycogen synthase kinase 3β. [PDF]
Yu T+9 more
europepmc +1 more source
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer. [PDF]
Uehara M+6 more
europepmc +1 more source
Glycogen Synthase Kinase-3 Beta (GSK3β) as a Potential Drug Target in Regulating Osteoclastogenesis: An Updated Review on Current Evidence. [PDF]
Wong SK.
europepmc +1 more source
Correction: Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression. [PDF]
Mishra R, Nagini S, Rana A.
europepmc +1 more source
Association of glycogen synthase kinase-3β with cognitive impairment in type 2 diabetes patients: a six-year follow-up study. [PDF]
Wei W+8 more
europepmc +1 more source
Inhibition of mitochondrial cyclophilin D, a downstream target of glycogen synthase kinase 3α, improves sperm motility. [PDF]
Park SH, Gye MC.
europepmc +1 more source
Regulation of Phosphorylation of Glycogen Synthase Kinase 3α and the Correlation with Sperm Motility in Human. [PDF]
Park SH+5 more
europepmc +1 more source
Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue. [PDF]
Turkistani A+8 more
europepmc +1 more source
Expression of Concern "Glycogen synthase kinase-3β inhibition attenuates the development of bleomycin-induced lung injury". [PDF]
europepmc +1 more source